Capital Markets
O’Melveny’s global Capital Markets team helps issuers and investment banks successfully execute a broad spectrum of strategic and capital-raising transactions.
“Excellent, smart, creative, hard-working, and very client service-oriented”
—Client Testimonial, ILFR1000
O’Melveny’s global Capital Markets team helps issuers and investment banks successfully execute a broad spectrum of strategic and capital-raising transactions.
“Excellent, smart, creative, hard-working, and very client service-oriented”
—Client Testimonial, ILFR1000
No matter the deal, we have the expertise to get it done. Our diverse group of lawyers have the track record of successfully guiding our clients through all types of strategic and capital-raising transactions across an array of industries, including technology, health care, media, energy financial, communications, retail, real estate, and energy.
Our global Capital Markets team has led some of the biggest, highest profile, and most complex deals. Our experience enables us to see challenges from the perspectives of every key player—companies, investment banks, regulators and investors. As a result, we navigate deals seamlessly. We also offer our clients the insight and expertise needed to avoid regulatory pitfalls from the start. Our team comprises lawyers with decades of experience addressing public company issues as outside counsel, former in-house counsel, former board members, and former senior officials serving within the SEC and other regulatory bodies.
Working hand-in-hand with our public company advisory team and SEC regulatory experts, clients rely on us to help them achieve the full spectrum of capital markets transactions, including:
- IPOs and secondary and follow-on stock offerings
- Investment-grade and high-yield debt offerings
- Convertible notes and other equity-linked securities offerings
- Medium-term note programs
- Liability-management transactions, such as tender offers, exchange offers, consent solicitations, amendments, and waivers
- Spin-offs, split-offs, and other carve-out transactions
- Equity forwards and other complex derivative transactions
- Rule 144A, Regulation S, Section 4(a)(2) / Regulation D, PIPEs and other unregistered offerings
- At-the-market programs
- Block trades and bought deals
- Direct listings and other stock exchange listings
Advised Akeso Biopharma, a leading Chinese clinical-stage biopharmaceutical company specializing in oncology and immunology therapies, in its listing and IPO on the Hong Kong Stock Exchange.
Represented AT&T Inc. in its two simultaneous tender offers to purchase for cash 54 series of outstanding Notes (the “Higher Coupon Offers”) and 9 series of outstanding Notes (the “Discount Offers”), in accordance with an SEC No-Action Letter permitting debt tender offers to be completed in as little as five business days.
Advised B. Riley Securities, Inc., a leading middle market investment bank, as sole placement agent in connection with the private placement financing of Series A preferred stock and warrants of Ribbon Communications Inc., a global provider of real time communications technology and IP optical networking solutions.
Represented Cepton, a Silicon Valley innovator and leader in high-performance MMT® lidar solutions, in its deSPAC transaction with Growth Capital Acquisition Corp. The combined company was renamed Cepton, Inc., and its common stock and warrants now trade on the Nasdaq Capital Market.
Represented the underwriters in LendingClub’s US$1 billion initial public offering on the NYSE.
Represented Liberty Broadband Corp. in its private offering of US$1.2 billion of 3.125% aggregate original principal amount of exchangeable senior debentures due 2053 and its tender offers for US$1.4 billion in aggregate principal amount of debentures.
Represented Liberty Media Corp. on its private offering of $575 million aggregate principal amount of its 3.75% convertible senior notes due 2028, including notes with an aggregate principal amount of $75 million issued pursuant to the exercise of an option granted to the initial purchasers, which was exercised in full.
O’Melveny also represented client in the use of proceeds from the offering, together with other cash, to repurchase outstanding indebtedness and proportionally terminate and unwind the bond hedges and warrants related to such repurchased indebtedness.
O’Melveny also represented client in the use of proceeds from the offering, together with other cash, to repurchase outstanding indebtedness and proportionally terminate and unwind the bond hedges and warrants related to such repurchased indebtedness.
Represented RemeGen Co. in its US$588 million IPO and primary listing on the Hong Kong Stock Exchange, advising on both Hong Kong and US law.
Represented the underwriters, led by BNP Paribas, Citigroup, Mizuho Securities, and TD Securities, in the largest Toyota Motor Credit Corp. global notes offering in the last decade.